Triggered Palliative Care for Advanced Dementia
Primary Purpose
Alzheimer Disease, Dementia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Specialty Palliative Care
Sponsored by
About this trial
This is an interventional supportive care trial for Alzheimer Disease
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of dementia from Alzheimer's or other underlying cause
- Global Deterioration Scale (GDS) Stage 5, 6 or 7
- acute illness hospitalization
Exclusion Criteria:
- No English-speaking family decision-maker
- Primary physician expects study to be too stressful for family caregiver
Sites / Locations
- University of North Carolina
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Specialty Palliative Care
Control
Arm Description
Specialty inter-disciplinary Palliative Care consultation during hospitalization with post-discharge collaborative care by a Palliative Care Nurse Practitioner and outpatient primary care physician. Clinical care will be augmented by evidence-based educational materials for dementia caregivers.
Usual care.
Outcomes
Primary Outcome Measures
Hospital / Emergency Visits Per 60 Days (no. of Events/Follow-up Days)
Includes emergency department visits and hospital admissions during measure interval
Secondary Outcome Measures
Patient Comfort End of Life in Dementia (CAD-EOLD)
Comfort at the End of Life in Dementia (CAD-EOLD) instrument, consisting of 14 Likert-scaled items measuring comfort in the final phase of life with dementia. Scores range from 14-42, with higher scores indicting greater comfort.
Caregiver Strain
Family Distress in Advanced Dementia instrument, a 21 item questionnaire designed to detect strain in family caregivers in dementia. Caregivers are asked a series of items about emotional distress, preparedness, and relations with healthcare providers scored 1-5, with higher scores indicting greater distress.
Percent of Participants With Referral to Hospice or Outpatient Palliative Care From Discharge to 60 Days Follow-Up
Percent of patients with referral to hospice or outpatient palliative care from discharge to 60 days follow-up from family interviews.
Percent of Participants With Physician Orders for Life Sustaining Treatment (POLST)
Percent of participants with POLST (Physician Orders for Life Sustaining Treatment) form completed and signed
Number of Palliative Care Domains in Treatment Plan
Number of palliative care domains addressed in treatment plan, using the Palliative Care Domain score which is scored 0 (not addressed) or 1 (addressed) for each of 10 possible domains of a palliative care treatment plan -- prognosis, overall goals of care, physical symptoms, psychiatric symptoms, spiritual needs, and 5 treatment preferences: resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization. Scores are summed for a total possible score of 0-10, with higher scores indicating greater attention to palliative care needs in the treatment plan.
Number of Participants With Burdensome Treatments
Number of participants with burdensome treatments, defined as a count of participants with any use of the following treatments: feeding tube, central intravenous line, surgical procedure, intensive care transfer, ventilator use, cardiopulmonary resuscitation use at any time during the time frame of measurement.
Full Information
NCT ID
NCT02719938
First Posted
March 21, 2016
Last Updated
January 7, 2019
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Icahn School of Medicine at Mount Sinai, National Institute on Aging (NIA)
1. Study Identification
Unique Protocol Identification Number
NCT02719938
Brief Title
Triggered Palliative Care for Advanced Dementia
Official Title
Triggered Palliative Care for Advanced Dementia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
March 2016 (Actual)
Primary Completion Date
October 31, 2017 (Actual)
Study Completion Date
October 31, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
Icahn School of Medicine at Mount Sinai, National Institute on Aging (NIA)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is to generate preliminary data for a large multi-site randomized clinical trial of a model of palliative care consultation for patients with advanced dementia, and for their family caregivers.
Detailed Description
Alzheimer's disease and related dementias affect 5 million Americans at an annual cost of $215 billion. Dementia is a contributing cause for 1 in 3 deaths, and is the only major cause of death with no effective prevention or treatment. Dementia-specific palliative care is needed to address the unique symptoms and treatment decisions relevant to this disease.
Investigators therefore propose to develop and pilot test a model of palliative care consultation for advanced dementia patients, triggered by hospitalization for a serious acute illness. After systematic refinement of operational protocols and tools with stakeholders, they will enroll persons with advanced dementia plus an acute illness associated with high risk of death in the coming year. Patients will be enrolled with their family decision-makers (N=60 dyads) in a randomized feasibility trial. Intervention dyads will receive specialty palliative care consultation during hospital admission, plus post-discharge collaborative care by their outpatient primary care provider and a palliative care nurse practitioner. Control dyads will receive usual care.
The research objective is to generate preliminary data for a large multi-site randomized controlled trial of a model of palliative care consultation for advanced dementia.
Specific aims are:
Aim 1: To develop a best-practice model of palliative care consultation for advanced dementia triggered by hospital admission for serious acute illness.
Aim 2: To conduct a pilot randomized trial of triggered palliative care consultation for advanced dementia (versus usual care) to demonstrate the feasibility of conducting a larger randomized trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease, Dementia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Specialty Palliative Care
Arm Type
Experimental
Arm Description
Specialty inter-disciplinary Palliative Care consultation during hospitalization with post-discharge collaborative care by a Palliative Care Nurse Practitioner and outpatient primary care physician. Clinical care will be augmented by evidence-based educational materials for dementia caregivers.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care.
Intervention Type
Behavioral
Intervention Name(s)
Specialty Palliative Care
Intervention Description
Specialty inter-disciplinary Palliative Care consultation during hospitalization with post-discharge collaborative care by a Palliative Care Nurse Practitioner and outpatient primary care physician. Clinical care will be augmented by evidence-based educational materials for dementia caregivers.
Primary Outcome Measure Information:
Title
Hospital / Emergency Visits Per 60 Days (no. of Events/Follow-up Days)
Description
Includes emergency department visits and hospital admissions during measure interval
Time Frame
From time of hospital discharge up to 60 days
Secondary Outcome Measure Information:
Title
Patient Comfort End of Life in Dementia (CAD-EOLD)
Description
Comfort at the End of Life in Dementia (CAD-EOLD) instrument, consisting of 14 Likert-scaled items measuring comfort in the final phase of life with dementia. Scores range from 14-42, with higher scores indicting greater comfort.
Time Frame
60 days
Title
Caregiver Strain
Description
Family Distress in Advanced Dementia instrument, a 21 item questionnaire designed to detect strain in family caregivers in dementia. Caregivers are asked a series of items about emotional distress, preparedness, and relations with healthcare providers scored 1-5, with higher scores indicting greater distress.
Time Frame
Interview at 60 days after hospitalization
Title
Percent of Participants With Referral to Hospice or Outpatient Palliative Care From Discharge to 60 Days Follow-Up
Description
Percent of patients with referral to hospice or outpatient palliative care from discharge to 60 days follow-up from family interviews.
Time Frame
From time of hospital discharge up to 60 days
Title
Percent of Participants With Physician Orders for Life Sustaining Treatment (POLST)
Description
Percent of participants with POLST (Physician Orders for Life Sustaining Treatment) form completed and signed
Time Frame
From time of hospital discharge up to 60 days
Title
Number of Palliative Care Domains in Treatment Plan
Description
Number of palliative care domains addressed in treatment plan, using the Palliative Care Domain score which is scored 0 (not addressed) or 1 (addressed) for each of 10 possible domains of a palliative care treatment plan -- prognosis, overall goals of care, physical symptoms, psychiatric symptoms, spiritual needs, and 5 treatment preferences: resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization. Scores are summed for a total possible score of 0-10, with higher scores indicating greater attention to palliative care needs in the treatment plan.
Time Frame
From time of hospital discharge up to 60 days
Title
Number of Participants With Burdensome Treatments
Description
Number of participants with burdensome treatments, defined as a count of participants with any use of the following treatments: feeding tube, central intravenous line, surgical procedure, intensive care transfer, ventilator use, cardiopulmonary resuscitation use at any time during the time frame of measurement.
Time Frame
From time of hospital discharge up to 60 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of dementia from Alzheimer's or other underlying cause
Global Deterioration Scale (GDS) Stage 5, 6 or 7
acute illness hospitalization
Exclusion Criteria:
No English-speaking family decision-maker
Primary physician expects study to be too stressful for family caregiver
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Hanson, MD, MPH
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
Data sharing plan not written
Citations:
PubMed Identifier
30342242
Citation
Hanson LC, Kistler CE, Lavin K, Gabriel SL, Ernecoff NC, Lin FC, Sachs GA, Mitchell SL. Triggered Palliative Care for Late-Stage Dementia: A Pilot Randomized Trial. J Pain Symptom Manage. 2019 Jan;57(1):10-19. doi: 10.1016/j.jpainsymman.2018.10.494. Epub 2018 Oct 18.
Results Reference
derived
Learn more about this trial
Triggered Palliative Care for Advanced Dementia
We'll reach out to this number within 24 hrs